Mycobacterium indicus pranii therapy induces tumor regression in MyD88- and TLR2-dependent manner

Keyphrases

• Antigen-presenting Cells 8%
• Antitumor Efficacy 33%
• Atypical Mycobacteria 8%
• B16F10 8%
• Dendritic Cells 16%
• Macrophage Activation 8%
• Macrophage Cells 16%
• Mycobacterial Species 8%
• Mycobacterium Indicus Pranii 100%
• Myeloid Differentiation Factor 88 (MyD88) 100%
• Phosphate-buffered Saline 25%
• Signaling Axis 16%
• TLR2 Signaling 16%
• Toll-like Receptor 2 (TLR2) 100%
• Toll-like Receptor 4 (TLR4) 16%
• Tumor 8%
• Tumor Burden 8%
• Tumor Cells 8%
• Tumor Growth 8%
• Tumor Immunity 8%
• Tumor Regression 100%
• Tumor Volume 8%
• Wild Mice 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Atypical Mycobacterium 8%
• Mycobacterium Indicus Pranii 100%
• Myeloid Differentiation Factor 88 100%
• Neoplasm 25%
• Phosphate Buffered Saline 25%
• Toll Like Receptor 2 100%
• Toll Like Receptor 4 16%
• Tumor Growth 8%
• Tumor Regression 100%
• Wild Type Mouse 8%

Immunology and Microbiology

• Antigen-Presenting Cell 8%
• Dendritic Cell 16%
• Macrophage 16%
• Mycobacterium Indicus Pranii 100%
• Nontuberculous mycobacteria 8%
• TLR2 100%
• TLR4 16%
• Tumor Cell 8%
• Tumor Volume 16%
• Wild Type 25%
• Wild Type Mouse 8%